Verastem Bid for Nearly $10 Million from California Nixed
A Massachusetts firm called Verastem, Inc., heard some bad news recently about its pitch for $9.9 million from the $3 billion California stem cell agency.
The Cambridge firm sought the cash from the agency to help out with a clinical trial dealing with breast cancer.
However, the agency’s directors were told in a memo on the CIRM Web site,
“Weaknesses in …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.